St. Jude Medical (STJ) Scheduled to Post Earnings on Wednesday
St. Jude Medical (NYSE:STJ) is set to post its quarterly earnings results on Wednesday, January 22nd. Investors interested in participating in the company’s conference call can do so using this link.
Shares of St. Jude Medical (NYSE:STJ) opened at 65.90 on Tuesday. St. Jude Medical has a 1-year low of $38.73 and a 1-year high of $68.39. The stock has a 50-day moving average of $61.79 and a 200-day moving average of $55.65. The company has a market cap of $19.230 billion and a P/E ratio of 27.28.
The company also recently declared a quarterly dividend, which is scheduled for Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a dividend of 0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend is Friday, December 27th.
Several analysts have recently commented on the stock. Analysts at Wedbush raised their price target on shares of St. Jude Medical from $62.00 to $73.00 in a research note to investors on Tuesday, January 14th. On a related note, analysts at Barclays reiterated an “overweight” rating on shares of St. Jude Medical in a research note to investors on Thursday, January 9th. They now have a $72.00 price target on the stock, up previously from $65.00. Finally, analysts at BTIG Research initiated coverage on shares of St. Jude Medical in a research note to investors on Tuesday, January 7th. They set a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have issued a buy rating to the company. St. Jude Medical presently has a consensus rating of “Buy” and an average price target of $56.44.
St. Jude Medical, Inc (NYSE:STJ) develops, manufactures and distributes cardiovascular medical devices.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.